News | Page 5 of 18 | Endeavour Vision

Relievant Medsystems Announces Highest Quality of Evidence Ranking for Basivertebral Nerve Ablation in ASPN Back Guideline for Interventional Low Back Pain Treatments

MINNEAPOLIS, Jan. 05, 2023 (GLOBE NEWSWIRE) -- Relievant Medsystems, a company dedicated to transforming the diagnosis and treatment of vertebrogenic pain, a type of chronic low back pain (CLBP), today announced that basivertebral nerve (BVN) ablation received a Grade A Quality of Evidence Ranking with High Level of Certainty [...]

Sarbjit Kunar2023-03-30T14:43:26+01:00January 9th, 2023|All News, Blog|

Interview with Tyler Binney, CEO of Relievant

Tyler Binney joined Relievant as President and CEO in 2021. We interviewed him to learn about Relievant’s breakthrough Intracept® Procedure, which could bring relief to tens of millions of US adults living with disabling vertebrogenic lower back pain. Tell us about chronic lower back pain. How does it impact [...]

Sarbjit Kunar2023-03-30T15:21:22+01:00December 13th, 2022|All News, Blog|

HealthJoy Raises $60M Series D to Power HR Leaders Through a New Era of Workplace and Healthcare Benefits

CHICAGO, Oct. 27, 2022 - HealthJoy, a healthcare navigation platform that drives benefits satisfaction, improves care outcomes, improves employee satisfaction and reduces HR burden, today announced it has raised $60M in Series D funding. Valspring Capital led the round with participation from new investors Endeavour Vision and CIBC Innovation [...]

Sarbjit Kunar2023-03-28T14:41:47+01:00October 27th, 2022|All News, Blog, Company News, Investment, Medtech|

Endeavour Vision adds Kestra Medical Technologies to EMG II Portfolio

Endeavour Vision is pleased to announce the addition of Kestra Medical Technologies to its portfolio – a company poised to disrupt the billion-dollar wearable cardioverter defibrillator (WCD) market. Kestra is bringing much-needed innovation to patients at risk of sudden cardiac arrest. Kestra’s ASSURE WCD automatically detects the irregularities in [...]

Sarbjit Kunar2023-03-28T14:42:45+01:00August 26th, 2022|All News, Blog, Company News, Investment, Medtech|

Nalu Medical, Inc. Names Thomas West President and Chief Executive Officer

CARLSBAD, CALIFORNIA, July 14, 2022 – Nalu Medical, Inc. (“Nalu”), a private company focused on innovative and minimally invasive solutions for chronic neuropathic pain, announced today that the Board of Directors has appointed Thomas “Tom” West as President and Chief Executive Officer. This leadership appointment is effective on August [...]

Sarbjit Kunar2023-02-22T12:06:39+00:00July 15th, 2022|All News, Company News|

IntelyCare Announces 900,000 Enrollments in IntelyEdu, Empowering Nursing Professionals With Affordable, Innovative Access to Continuing Education

IntelyEdu breaks down education barriers by providing nursing continuing professional development (NCPD) credits and career advancement opportunities through on-demand learning and exclusive partnerships June 16, 2022. QUINCY, Mass. IntelyCare, the leading tech-enabled nurse staffing platform for healthcare organizations in the United States, today announced the formal launch of IntelyEdu, [...]

Sarbjit Kunar2023-03-28T14:43:18+01:00June 22nd, 2022|All News, Blog|

FLEX Vessel Prep AV Registry Data Shows A Longer Lasting Solution to Standalone PTA When Treating AV Access Fistulas and Grafts

MINNEAPOLIS, June 15, 2022 /PRNewswire/ -- VentureMed Group, Inc., a privately held medical device innovator in access management for arteriovenous (AV) fistulas and grafts and vessel preparation for interventional treatment of peripheral arterial disease (PAD) announced data presented at the Vascular Access Societies of the Americas (VASA) June 9-11, [...]

Sarbjit Kunar2023-03-28T14:44:46+01:00June 21st, 2022|All News, Company News|

Interview with Bradley Paddock on CeQur Simplicity

In just over a year, CeQur® has reached major milestones in financing, company growth and the pilot launch of its three-day insulin delivery device for type 2 diabetes, CeQur Simplicity™. In this interview, CEO Bradley Paddock explains how the company is navigating this trajectory and scaling up to positively [...]

Sarbjit Kunar2023-04-03T11:12:07+01:00June 15th, 2022|All News, Blog|

Medartis completes acquisition of Nextremity Solutions Inc. and announces new US leadership

Basel, Switzerland, 3 May 2022 - Medartis Holding AG (SIX: MED) announced today that it has completed the acquisition of Nextremity Solutions Inc., a strategic commercialisation organisation located in Warsaw, USA. The total purchase price for the transaction will be up to USD 70 million and includes milestone and [...]

Sarbjit Kunar2023-04-03T11:19:57+01:00May 3rd, 2022|All News, Company News|

Virtual Incision Announces Approval to Complete Clinical Study Enrollment for its MIRA® Platform

FDA decision supported by an interim clinical study report on patient safety Lincoln, Neb. – April 19, 2022 – Virtual Incision Corporation, a medical device company pioneering the world’s first miniaturized robotic-assisted surgery (RAS) platform, today announced the U.S. Food and Drug Administration (FDA) has approved an Investigational Device [...]

Sarbjit Kunar2023-03-28T14:49:36+01:00April 20th, 2022|All News, Company News|